News

2012 WGND Annual Meeting is Nov 14 in Kuala Lumpur

We invite you to join us for the Stop TB Partnership Working Group on New Drugs’ 2012 Annual Meeting at the Impiana KLCC Hotel in Kuala Lumpur, Malaysia on Wednesday, November 14.

Also, we are sponsoring a lunch to allow the Sub-groups (Biology/Targets, Candidates, Critical Knowledge and Tools, and Clinical Trial Capacity) to meet and plan for activities for 2013. Please make plans to attend both events.

Event: WGND Sub-groups Working Lunch

WHEN: Wednesday, November 14, 2012, 12:00 to 13:00

WHERE: Impiana KLCC Hotel, 13, Jalan Pinang, 50450 Kuala Lumpur, Malaysia

DESCRIPTION: All WGND members and those interested in becoming members who will be attending the events in Kuala Lumpur are invited to a lunch sponsored by the WGND. The lunch will be an opportunity for members of each WGND Subgroup (Biology/Targets, Candidates, Critical Knowledge and Tools, Clinical Trial Capacity) to discuss and plan for 2013 activities and provide feedback on 2012 activities. If you have not officially joined a specific subgroup, we encourage you to attend the lunch and take the opportunity to see what the subgroups are doing and join in the discussions.


Event: 2012 WGND Annual Meeting

WHEN: Wednesday, November 14, 2012, 13:00 to 17:30

WHERE: Impiana KLCC Hotel, 13, Jalan Pinang, 50450 Kuala Lumpur, Malaysia

DESCRIPTION: The WGND will host our annual meeting at the start of the 43rd Union World Conference on Lung Health (The Union) in Kuala Lumpur, Malaysia. During the meeting we will review and discuss progress of projects in the Global TB Drug Pipeline and Drug Discovery Portfolio, review WGND 2012 activities, and discuss other relevant topics. Representatives from pharmaceutical companies, research consortia and organizations, NGOs and academia will be participating.

More News
23 Aug 2022
Last week, the PAN-TB collaboration announced initial plans for a Phase 2 clinical trial evaluating two novel drug regimens to treat Tuberculosis. Sponsored by the Bill and Melinda Gates Foundation, the PAN-TB, or “Project to Accelerate New Treatments for Tuberculosis”, collaboration brings...
4 May 2022
Earlier this week, the World Health Organization (WHO) released a rapid communication which detailed the upcoming changes to the treatment guidance for drug-resistant tuberculosis (DR-TB). These guidelines are used to inform national TB programmes globally on how to treat patients with these...
5 Apr 2022
On April 01, 2022, the Stop TB Partnership launched the second online consultation for the new Global Plan to End TB 2023-2030. Over the years, the Global Plans have been important tools for advocacy and resource mobilization, and served as a reference document for donors and stakeholders. In May...